FDAnews Drug Daily Bulletin

BENTLEY PHARMA SIGNS LICENSING AGREEMENT

Nov. 16, 2005
A A

Bentley Pharmaceuticals Inc., a drugmaker and developer of drug-delivery systems, said Monday it signed a licensing agreement spanning 85 countries with India's Biocon Ltd. for Bentley's insulin-administering nasal spray. The agreement grants Biocon rights to develop and market the product throughout Asia, Africa and the Middle East, the company said. Bentley did not disclose terms of the agreement.

Boston Globe (http://www.boston.com/news/local/new_hampshire/articles/2005/11/14/bentley_pharma_signs_licensing_agreement/)